Figure 1.

Differences in total daily dose of insulin (A), average CGM glucose (B), percent of time CGM glucose was <70 mg/dL (C), and change in weight (D) while participants in the crossover study were taking placebo (red circles) or dapagliflozin (Dapa; blue circles) for 4 weeks. Median values are annotated above each column and represented by the bar. Dots depict individual values for each participant. P values determined by Wilcoxon matched-pairs signed rank tests are indicated above brackets. Within-participant differences (placebo minus dapagliflozin) for total daily dose of insulin (E), average (Avg) CGM glucose (F), and percent of time CGM glucose was <70 mg/dL (G). Black vertical lines signify the median differences for the entire study cohort.